Fighting the Rise of STIs with Doxycycline Postexposure Prophylaxis
As rates of gonorrhea, chlamydia, and syphilis climb across the United States, innovative solutions are needed to curb the spread of these harmful bacterial infections. Join us for an insightful webinar exploring the potential of doxycycline postexposure prophylaxis (doxy-PEP) as an effective sexual health strategy.
On Friday, September 22, 2023 at 2 PM EST, infectious disease expert Dr. Annie Luetkemeyer will review the latest CDC recommendations on utilizing doxy-PEP to reduce STI transmission. She will be joined by moderator Dr. Connie Celum to discuss proper doxy-PEP administration, determining appropriate candidates, and open questions regarding doxy-PEP use in patients living with HIV.
By the end of this engaging webinar, participants will be able to:
- Implement CDC guidelines on doxy-PEP in patients with HIV
- Understand optimal doxy-PEP timing and administration
- Evaluate unanswered questions about doxy-PEP and HIV
- As STIs continue to rise, innovative solutions like doxy-PEP are needed. Join us on 9/22 to learn how doxy-PEP can be leveraged to improve sexual health outcomes.
Read more – https://www.iasusa.org/events/webinar-2023-luetkemeyer/